Qingyang Feng

1.5k total citations
58 papers, 1.0k citations indexed

About

Qingyang Feng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Qingyang Feng has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Qingyang Feng's work include Colorectal Cancer Surgical Treatments (12 papers), Ferroptosis and cancer prognosis (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (10 papers). Qingyang Feng is often cited by papers focused on Colorectal Cancer Surgical Treatments (12 papers), Ferroptosis and cancer prognosis (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (10 papers). Qingyang Feng collaborates with scholars based in China, United States and Australia. Qingyang Feng's co-authors include Jianmin Xu, Guodong He, Dexiang Zhu, Meiling Ji, Ye Wei, Wenju Chang, Yihao Mao, Li Ren, Peng Zheng and Wentao Tang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Qingyang Feng

58 papers receiving 1.0k citations

Peers

Countries citing papers authored by Qingyang Feng

Since Specialization

Citations

This map shows the geographic impact of Qingyang Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyang Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyang Feng more than expected).

Fields of papers citing papers by Qingyang Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyang Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyang Feng. The network helps show where Qingyang Feng may publish in the future.

Co-authorship network of co-authors of Qingyang Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyang Feng. A scholar is included among the top collaborators of Qingyang Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyang Feng. Qingyang Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancer 2024 ·International Immunopharmacology ·Chang Jiang, Qingyang Feng, Yihao Mao, Zhiyuan Zhang, Yuqiu Xu, Yijiao Chen, Peng Zheng, (unknown), (unknown), (unknown), Ziqi Zhang, Guodong He, Jianmin Xu, Ye Wei	8
2	Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis 2023 ·International Journal of Biological Sciences ·(unknown), Wentao Tang, Yuqiu Xu, Wenju Chang, Zhiyuan Zhang, Lin Qi, Meiling Ji, Qingyang Feng, Guodong He, Jianmin Xu	40
3	HERC3 directly targets RPL23A for ubiquitination degradation and further regulates Colorectal Cancer proliferation and the cell cycle 2022 ·International Journal of Biological Sciences ·Zhiyuan Zhang, Qi Wu, (unknown), Yu Liu, (unknown), Qingyang Feng, Ronggui Hu, Jianmin Xu	13
4	Cullin-9/p53 mediates HNRNPC degradation to inhibit erastin-induced ferroptosis and is blocked by MDM2 inhibition in colorectal cancer 2022 ·Oncogene ·Yang Lv, (unknown), Zhiyuan Zhang, Qi Lin, Yuxiang Luo, Peng Zheng, Ke Li, (unknown), Yuzhi Pang, Meiling Ji, Qingyang Feng, Guodong He, Yuexiang Wang, Jianmin Xu	26
5	Comprehensive Analysis Reveals the Potential Regulatory Mechanism Between Ub–Proteasome System and Cell Cycle in Colorectal Cancer 2021 ·Frontiers in Cell and Developmental Biology ·Zhiyuan Zhang, Jingwen Chen, Wentao Tang, Qingyang Feng, Jianmin Xu, Li Ren	2
6	Isolation and characterization of a goose astrovirus 1 strain causing fatal gout in goslings, China 2021 ·Poultry Science ·Anping Wang, (unknown), Jun Xie, (unknown), Shuang Wu, Zhi Wu, (unknown), Qingyang Feng, (unknown), Susong Zhu	38
7	Significance of Surgery in the Treatment of Colorectal Cancer Ovarian Metastases: A Retrospective Case Matching Study 2021 ·Cancer Management and Research ·Yuqiu Xu, Qingyang Feng, Yijiao Chen, Yihao Mao, Zhiyuan Zhang, Yang Lv, Peng Zheng, (unknown), Guodong He, Jianmin Xu	2
8	A signature predicting relapse based on integrated analysis on relapse-associated alternative mRNA splicing in I–III rectal cancer 2020 ·Genomics ·Zhiyuan Zhang, Meiling Ji, Yang Lv, Qingyang Feng, Peng Zheng, Yihao Mao, Yuqiu Xu, Guodong He, Jianmin Xu	9
9	Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I–III colon cancer 2020 ·Genomics ·Zhiyuan Zhang, Qingyang Feng, (unknown), Peng Zheng, Yang Lv, Yihao Mao, Yuqiu Xu, Guodong He, Jianmin Xu	12
10	Tumor microenvironment derived signature predicting relapse-free survival in I-III cancer and preliminary experiment verification 2020 ·International Immunopharmacology ·Zhiyuan Zhang, Qi Wu, Dexiang Zhu, Guodong He, Qingyang Feng, Jianmin Xu	5
11	Benefits of multi‐disciplinary treatment strategy on survival of patients with colorectal cancer liver metastasis 2020 ·SHILAP Revista de lepidopterología ·Yang Lv, Qingyang Feng, Ye Wei, Li Ren, Qing‐Hai Ye, Xiaoying Wang, Yuehong Cui, Tianshu Liu, Bo Zhou, Mingliang Wang, Shengxiang Rao, Jian Wang, Jian‐Yong Ding, Guodong He, Jianmin Xu	12
12	Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer 2019 ·Clinical Cancer Research ·Qingyang Feng, Wenju Chang, Yihao Mao, Guodong He, Peng Zheng, Wentao Tang, Ye Wei, Li Ren, Dexiang Zhu, Meiling Ji, (unknown), Xinyu Qin, Jianmin Xu	104
13	Posttranscriptional regulation of MMP‐9 by HuR contributes to IL‐1β‐induced pterygium fibroblast migration and invasion 2019 ·Journal of Cellular Physiology ·Yuhong Cui, Qingyang Feng, Qun Liu, (unknown), (unknown), (unknown), Zhiyi Xu, Jiahui Li, Meijun Li, (unknown), Zhijie Li, Hongwei Pan	17
14	The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1–STAT3 signaling pathway 2019 ·Cell Death and Disease ·Qi Lin, Li Ren, Mi Jian, Pingping Xu, Jun Li, Peng Zheng, Qingyang Feng, Liangliang Yang, (unknown), Ye Wei, Jianmin Xu	56
15	<p>Exploration of exact significance of lymph node ratio and construction of a novel stage in colon cancer with no distant metastasis</p> 2019 ·Cancer Management and Research ·Yang Lv, Qingyang Feng, (unknown), Yihao Mao, Yuqiu Xu, Peng Zheng, Liangliang Yang, Guodong He, Jianmin Xu	7
16	Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer 2018 ·Cancer Management and Research ·Yihao Mao, Qingyang Feng, Peng Zheng, Liangliang Yang, Tianyu Liu, Yuqiu Xu, Dexiang Zhu, Wenju Chang, Meiling Ji, Li Ren, Ye Wei, Guodong He, Jianmin Xu	87
17	Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases 2018 ·Cancer Management and Research ·Peng Zheng, Li Ren, Qingyang Feng, Dexiang Zhu, Wenju Chang, Guodong He, Meiling Ji, Mi Jian, Qi Lin, (unknown), Ye Wei, Jianmin Xu	11
18	Effects of beyond KRAS mutations on the efficacy of cetuximab plus chemotherapy for patients with unresectable colorectal liver-limited metastases (BELIEF): a retrospective biomarker analysis from a Chinese trial 2016 ·Annals of Oncology ·Jianmin Xu, Li Ren, Ye Wei, Peng Zheng, (unknown), Qingyang Feng, (unknown), Dexiang Zhu, Wenju Chang, (unknown)	4
19	Application of multi-disciplinary team in the diagnosis and treatment of metastatic colorectal cancer 2014 ·Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi ·Qingyang Feng, Jianmin Xu	1
20	Aberrant expression of sphingosine-1-phosphate receptor 1 correlates with metachronous liver metastasis and poor prognosis in colorectal cancer 2014 ·Tumor Biology ·Qi Lin, Ye Wei, Yunshi Zhong, Dexiang Zhu, Li Ren, Pingping Xu, Peng Zheng, Qingyang Feng, Meiling Ji, Minzhi Lv, Chunmin Liang, Jianmin Xu	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact